Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug-Receptor Interactions01:29

Drug-Receptor Interactions

6.1K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
6.1K
Factors Affecting Protein-Drug Binding: Drug Interactions01:23

Factors Affecting Protein-Drug Binding: Drug Interactions

299
Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
299
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

4.9K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
4.9K
Drug-Receptor Bonds01:25

Drug-Receptor Bonds

3.3K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
3.3K
Drug-Receptor Interaction: Antagonist01:28

Drug-Receptor Interaction: Antagonist

3.6K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
3.6K
Combined Effects of Drugs: Antagonism01:30

Combined Effects of Drugs: Antagonism

9.4K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
9.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Machine Learning Identification of Cell-Type-Specific Molecular Signatures Distinguishing COVID-19 from Other Lower Respiratory Tract Diseases.

Life (Basel, Switzerland)·2026
Same author

HCLAMCMI: Prediction of circRNA-miRNA Interactions Based on Hypergraph Contrastive Learning and an Attention Mechanism.

Journal of chemical information and modeling·2025
Same author

Unveiling Immune Response Mechanisms in Mpox Infection Through Machine Learning Analysis of Time Series Gene Expression Data.

Life (Basel, Switzerland)·2025
Same author

Transcriptomic and miRNA Signatures of ChAdOx1 nCoV-19 Vaccine Response Using Machine Learning.

Life (Basel, Switzerland)·2025
Same author

Notch signaling pathway in osteogenesis, bone development, metabolism, and diseases.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2025
Same author

PMiSLocMF: predicting miRNA subcellular localizations by incorporating multi-source features of miRNAs.

Briefings in bioinformatics·2024

Related Experiment Video

Updated: Sep 22, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.8K

Drug-Drug Interactions Prediction Using Fingerprint Only.

Bing Ran1, Lei Chen1, Meijing Li1

  • 1College of Information Engineering, Shanghai Maritime University, Shanghai 201306, China.

Computational and Mathematical Methods in Medicine
|May 19, 2022
PubMed
Summary

This study introduces a simple computational method to predict drug-drug interactions (DDIs) using drug fingerprints and random forest. The DDIPF web server offers a user-friendly tool for discovering novel DDIs.

More Related Videos

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

12.0K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.3K

Related Experiment Videos

Last Updated: Sep 22, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.8K
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

12.0K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.3K

Area of Science:

  • Computational chemistry
  • Pharmacology
  • Bioinformatics

Background:

  • Drug-drug interactions (DDIs) pose significant patient safety risks in combination drug therapy.
  • Traditional methods for DDI determination (in vitro, clinical trials) are not scalable for large-scale testing.
  • Existing computational DDI prediction methods often require extensive drug information, limiting their applicability.

Purpose of the Study:

  • To develop a simple yet effective computational method for predicting drug-drug interactions (DDIs).
  • To address the limitations of existing DDI prediction approaches by utilizing readily available drug fingerprint features.
  • To provide a user-friendly tool for DDI prediction to aid in drug discovery and patient safety.

Main Methods:

  • Drugs were represented using their widely adopted fingerprint features.
  • These features were refined using addition, subtraction, and Hadamard models to create DDI representations.
  • A random forest classification algorithm was employed to build the predictive model.

Main Results:

  • The developed classifier demonstrated good performance in discovering novel DDIs among known drugs.
  • Acceptable performance was achieved in identifying DDIs involving unknown drugs.
  • The method outperformed other approaches that used advanced feature generation algorithms.

Conclusions:

  • The proposed simple computational method effectively predicts drug-drug interactions using drug fingerprints.
  • The DDIPF web server provides a valuable resource for DDI prediction, enhancing drug safety and discovery.
  • This approach offers a scalable and accessible alternative to traditional DDI determination methods.